Mini Review
Published on 25 Aug 2022
Physical activity to reduce PCSK9 levels
in Lipids in Cardiovascular Disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.988698
- 3,932 views
- 3 citations
Type at least 3 characters
249 articles
Original Research
Published on 22 Aug 2022
Isoprenaline modified the lipidomic profile and reduced β-oxidation in HL-1 cardiomyocytes: In vitro model of takotsubo syndrome
in Lipids in Cardiovascular Disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.917989
- 4,618 views
- 5 citations
Review
Published on 22 Aug 2022
Diabetic dyslipidemia impairs coronary collateral formation: An update
in Lipids in Cardiovascular Disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.956086
- 4,089 views
- 7 citations
Original Research
Published on 18 Aug 2022
The accuracy of four formulas for LDL-C calculation at the fasting and postprandial states
in Lipids in Cardiovascular Disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.944003
- 4,966 views
- 4 citations
Original Research
Published on 17 Aug 2022
Cardiac immune cell infiltration associates with abnormal lipid metabolism
in Lipids in Cardiovascular Disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.948332
- 5,138 views
- 3 citations
Case Report
Published on 16 Aug 2022
Pediatric patients with familially inherited sitosterolemia: Two case reports
in Lipids in Cardiovascular Disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.927267
- 2,666 views
- 4 citations
Original Research
Published on 16 Aug 2022
Efficacy and safety of hybutimibe in combination with atorvastatin for treatment of hypercholesteremia among patients with atherosclerotic cardiovascular disease risk equivalent: A multicenter, randomized, double-blinded phase III study
in Lipids in Cardiovascular Disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.888604
- 3,963 views
- 3 citations
Review
Published on 09 Aug 2022
Cancer therapy's impact on lipid metabolism: Mechanisms and future avenues
in Lipids in Cardiovascular Disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.925816
- 9,589 views
- 23 citations
Original Research
Published on 09 Aug 2022
β-sheets in serum protein are independent risk factors for coronary lesions besides LDL-C in coronary heart disease patients
in Lipids in Cardiovascular Disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.911358
- 2,858 views
- 1 citation
Review
Published on 08 Aug 2022
Gender dimension in cardio-pulmonary continuum
in Lipids in Cardiovascular Disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.916194
- 6,386 views
- 3 citations
Case Report
Published on 08 Aug 2022
Case report: Unusual coexistence between familial hypercholesterolemia and familial hypobetalipoproteinemia
in Lipids in Cardiovascular Disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.942772
- 2,178 views
- 1 citation
Study Protocol
Published on 04 Aug 2022
Treatment patterns and use of healthcare resources of patients with atherosclerotic cardiovascular disease and hypercholesterolemia and patients with familial hypercholesterolemia in Spain: Protocol of the Reality study
in Lipids in Cardiovascular Disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.966049
- 4,704 views
- 7 citations
Original Research
Published on 27 Jul 2022
The relationship of remnant cholesterol and abdominal obesity in children: A cross-sectional study
in Lipids in Cardiovascular Disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.929560
- 2,476 views
- 9 citations
Original Research
Published on 26 Jul 2022
Trajectory of low-density lipoprotein cholesterol in patients with chronic kidney disease and its association with cardiovascular disease
in Lipids in Cardiovascular Disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.887915
- 3,027 views
- 1 citation
Original Research
Published on 26 Jul 2022
An intensive, structured, mobile devices-based healthcare intervention to optimize the lipid-lowering therapy improves lipid control after an acute coronary syndrome
in Lipids in Cardiovascular Disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.916031
- 2,189 views
- 1 citation
Original Research
Published on 15 Jul 2022
Optimized Treatment of Refractory Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease or Heterozygous Familial Hypercholesterolemia With Alirocumab (OPTIMIZE)
in Lipids in Cardiovascular Disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.953040
- 2,885 views